Dr. Aseem Malhotra

Yeah, Megan. So, you know, I've thought about this in a lot of depth because, you know, I'm somebody that's been a very outspoken advocate of evidence-based medicine. I mean, I've published extensively. I've worked in advisory government roles over the years. And everything I usually advocate for comes through medical journal articles that I've published that have been peer reviewed.

Yeah, Megan. So, you know, I've thought about this in a lot of depth because, you know, I'm somebody that's been a very outspoken advocate of evidence-based medicine. I mean, I've published extensively. I've worked in advisory government roles over the years. And everything I usually advocate for comes through medical journal articles that I've published that have been peer reviewed.

Usually nothing to do with the drug industry in terms of those articles. They're usually analysis, independent analyses. And just to give people, you know, people can get confused here, but essentially when you look at the evidence right now in terms of the COVID vaccine, specifically I, you know, emphasize and look to mRNA vaccines, so Pfizer, Moderna. People know that the serious harm is there.

Usually nothing to do with the drug industry in terms of those articles. They're usually analysis, independent analyses. And just to give people, you know, people can get confused here, but essentially when you look at the evidence right now in terms of the COVID vaccine, specifically I, you know, emphasize and look to mRNA vaccines, so Pfizer, Moderna. People know that the serious harm is there.

Usually nothing to do with the drug industry in terms of those articles. They're usually analysis, independent analyses. And just to give people, you know, people can get confused here, but essentially when you look at the evidence right now in terms of the COVID vaccine, specifically I, you know, emphasize and look to mRNA vaccines, so Pfizer, Moderna. People know that the serious harm is there.

The question is, how frequent is it? And the data comes from what we call randomized controlled trial, reanalysis of Pfizer and Moderna's trials, pharmacovigilance data, what people are reporting on the yellow card system, autopsy data we know now, certainly more than 70% of people that died within a couple of weeks of having the vaccine or were certainly caused by the vaccine, that's been proven.

The question is, how frequent is it? And the data comes from what we call randomized controlled trial, reanalysis of Pfizer and Moderna's trials, pharmacovigilance data, what people are reporting on the yellow card system, autopsy data we know now, certainly more than 70% of people that died within a couple of weeks of having the vaccine or were certainly caused by the vaccine, that's been proven.

The question is, how frequent is it? And the data comes from what we call randomized controlled trial, reanalysis of Pfizer and Moderna's trials, pharmacovigilance data, what people are reporting on the yellow card system, autopsy data we know now, certainly more than 70% of people that died within a couple of weeks of having the vaccine or were certainly caused by the vaccine, that's been proven.

You've got observational data and, of course, my own clinical experience. So the serious adverse event rate on the best evidence we have, and this has not been rebutted, to be honest, in any, you know, serious platform, Megan, comes from reanalysis of Pfizer and Moderna's trials by independent scientists. Joseph Freeman is a lead scientist who works very closely with Jay Bhattacharya, by the way.

You've got observational data and, of course, my own clinical experience. So the serious adverse event rate on the best evidence we have, and this has not been rebutted, to be honest, in any, you know, serious platform, Megan, comes from reanalysis of Pfizer and Moderna's trials by independent scientists. Joseph Freeman is a lead scientist who works very closely with Jay Bhattacharya, by the way.

You've got observational data and, of course, my own clinical experience. So the serious adverse event rate on the best evidence we have, and this has not been rebutted, to be honest, in any, you know, serious platform, Megan, comes from reanalysis of Pfizer and Moderna's trials by independent scientists. Joseph Freeman is a lead scientist who works very closely with Jay Bhattacharya, by the way.

You've got Peter Doshi, associate editor of the BMJ. And what they found was that the serious adverse event rate was at least one in 800 at two months. And that means disability, life-changing rate, hospitalization.

You've got Peter Doshi, associate editor of the BMJ. And what they found was that the serious adverse event rate was at least one in 800 at two months. And that means disability, life-changing rate, hospitalization.

You've got Peter Doshi, associate editor of the BMJ. And what they found was that the serious adverse event rate was at least one in 800 at two months. And that means disability, life-changing rate, hospitalization.

And from the original trials that got approved around the world, Megan, you're more likely to suffer serious harm from the vaccine than you were to be hospitalized with COVID, which suggests from the beginning it was going to do more harm than good.

And from the original trials that got approved around the world, Megan, you're more likely to suffer serious harm from the vaccine than you were to be hospitalized with COVID, which suggests from the beginning it was going to do more harm than good.

And from the original trials that got approved around the world, Megan, you're more likely to suffer serious harm from the vaccine than you were to be hospitalized with COVID, which suggests from the beginning it was going to do more harm than good.

But actually, where we are now, and this is, I think the UK government's probably the only government in the world that's published this, been transparent in publishing this information.

But actually, where we are now, and this is, I think the UK government's probably the only government in the world that's published this, been transparent in publishing this information.

But actually, where we are now, and this is, I think the UK government's probably the only government in the world that's published this, been transparent in publishing this information.